BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16892486)

  • 1. FPRL-1 induces modifications of migration-associated proteins in human neutrophils.
    Boldt K; Rist W; Weiss SM; Weith A; Lenter MC
    Proteomics; 2006 Sep; 6(17):4790-9. PubMed ID: 16892486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Formyl peptide receptor subtypes in human neutrophils activate L-plastin phosphorylation through different signal transduction intermediates.
    Paclet MH; Davis C; Kotsonis P; Godovac-Zimmermann J; Segal AW; Dekker LV
    Biochem J; 2004 Jan; 377(Pt 2):469-77. PubMed ID: 14556648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formyl peptide-receptor like-1 requires lipid raft and extracellular signal-regulated protein kinase to activate inhibitor-kappa B kinase in human U87 astrocytoma cells.
    Kam AY; Liu AM; Wong YH
    J Neurochem; 2007 Nov; 103(4):1553-66. PubMed ID: 17727628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor.
    Elagoz A; Henderson D; Babu PS; Salter S; Grahames C; Bowers L; Roy MO; Laplante P; Grazzini E; Ahmad S; Lembo PM
    Br J Pharmacol; 2004 Jan; 141(1):37-46. PubMed ID: 14662730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling.
    Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS
    Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
    Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1.
    El Zein N; Badran B; Sariban E
    Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
    Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
    Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast.
    Klein C; Paul JI; Sauvé K; Schmidt MM; Arcangeli L; Ransom J; Trueheart J; Manfredi JP; Broach JR; Murphy AJ
    Nat Biotechnol; 1998 Dec; 16(13):1334-7. PubMed ID: 9853614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation.
    El Kebir D; József L; Filep JG
    J Leukoc Biol; 2008 Sep; 84(3):600-6. PubMed ID: 18495783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formyl peptide receptor like 1 differentially requires mitogen-activated protein kinases for the induction of glial fibrillary acidic protein and interleukin-1alpha in human U87 astrocytoma cells.
    Kam AY; Tse TT; Kwan DH; Wong YH
    Cell Signal; 2007 Oct; 19(10):2106-17. PubMed ID: 17643960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.
    Hayhoe RP; Kamal AM; Solito E; Flower RJ; Cooper D; Perretti M
    Blood; 2006 Mar; 107(5):2123-30. PubMed ID: 16278303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-a tool in analysing receptor specific events.
    Fu H; Karlsson J; Björkman L; Stenfeldt AL; Karlsson A; Bylund J; Dahlgren C
    J Immunol Methods; 2008 Feb; 331(1-2):50-8. PubMed ID: 18166194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2.
    Migeotte I; Riboldi E; Franssen JD; Grégoire F; Loison C; Wittamer V; Detheux M; Robberecht P; Costagliola S; Vassart G; Sozzani S; Parmentier M; Communi D
    J Exp Med; 2005 Jan; 201(1):83-93. PubMed ID: 15623572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of N-formyl peptide receptors in human bone marrow-derived mesenchymal stem cells.
    Viswanathan A; Painter RG; Lanson NA; Wang G
    Stem Cells; 2007 May; 25(5):1263-9. PubMed ID: 17234990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-D Difference in gel electrophoresis combined with Pro-Q Diamond staining: a successful approach for the identification of kinase/phosphatase targets.
    Orsatti L; Forte E; Tomei L; Caterino M; Pessi A; Talamo F
    Electrophoresis; 2009 Jul; 30(14):2469-76. PubMed ID: 19639567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes.
    Sawmynaden P; Perretti M
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1351-5. PubMed ID: 16973129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil apoptosis: a target for enhancing the resolution of inflammation.
    Filep JG; El Kebir D
    J Cell Biochem; 2009 Dec; 108(5):1039-46. PubMed ID: 19760640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Formylated humanin activates both formyl peptide receptor-like 1 and 2.
    Harada M; Habata Y; Hosoya M; Nishi K; Fujii R; Kobayashi M; Hinuma S
    Biochem Biophys Res Commun; 2004 Nov; 324(1):255-61. PubMed ID: 15465011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment of opioid peptide-containing neutrophils is independent of formyl peptide receptors.
    Hackel D; Stolz A; Mousa SA; Brack A; Rittner HL
    J Neuroimmunol; 2011 Jan; 230(1-2):65-73. PubMed ID: 20869777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.